Loring Wolcott & Coolidge Fiduciary Advisors’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$37K	–	779
2019 Q1	$37K	Hold	3,000	–	–	﹤0.01%	436
2018 Q4	$18K	Hold	3,000	–	–	﹤0.01%	532
2018 Q3	$32K	Hold	3,000	–	–	﹤0.01%	458
2018 Q2	$41K	Hold	3,000	–	–	﹤0.01%	450
2018 Q1	$53K	Hold	3,000	–	–	﹤0.01%	439
2017 Q4	$38K	Hold	3,000	–	–	﹤0.01%	465
2017 Q3	$57K	Hold	3,000	–	–	﹤0.01%	417
2017 Q2	$34K	Hold	3,000	–	–	﹤0.01%	450
2017 Q1	$51K	Hold	3,000	–	–	﹤0.01%	409
2016 Q4	$36K	Hold	3,000	–	–	﹤0.01%	423
2016 Q3	$30K	Hold	3,000	–	–	﹤0.01%	445
2016 Q2	$31K	Sell	3,000 -2,500	-45%	-$27.9K	﹤0.01%	443
2016 Q1	$67K	Buy	5,500 +3,000	+120%	+$30.3K	﹤0.01%	360
2015 Q4	$40K	Hold	2,500	–	–	﹤0.01%	447
2015 Q3	$60K	Hold	2,500	–	–	﹤0.01%	404
2015 Q2	$60K	Hold	2,500	–	–	﹤0.01%	404
2015 Q1	$47K	Hold	2,500	–	–	﹤0.01%	440
2014 Q4	$47K	Buy	+2,500	New	+$58.4K	﹤0.01%	433